The particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Particle therapy is one of the most popular alternative treatment procedures for radiation therapy. With particle therapy systems, precise delivery of the radiation dose to the required tumor site is possible.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137

Market growth is driven by factors such as growing adoption of particle therapy in clinical trials and the increasing number of particle therapy centers worldwide. Emerging markets are China India, Brazil, and South Africa are showing lucrative growth opportunities to market.

“Pediatric cancer defined for the largest share in the particle therapy market by cancer type”

Based on cancer type, the particle therapy market is segmented into prostate cancer. pediatric cancer, lung cancer, breast cancer, head & neck cancer, and other cancers. The pediatric cancer segment is holds the largest share of 24.8% of the particle therapy market with CAGR of 10.4% during the forecast period.

Here are some key points about the particle therapy market:

Treatment Advantages: Particle therapy offers several advantages over traditional radiation therapy methods, such as X-rays or gamma rays. The main advantage is the ability to precisely target tumors, delivering a higher dose of radiation directly to the cancer cells while sparing nearby healthy tissues.

Growing Demand: The particle therapy market has been experiencing significant growth in recent years. This is due to several factors, including increasing cancer incidence rates, a growing aging population, and advancements in technology and research.

Cancer Treatment: Particle therapy is primarily used in the treatment of various types of cancer, including prostate, brain, lung, liver, and pediatric cancers. It can be particularly beneficial for tumors located near critical structures, such as the spinal cord or brain, where minimizing radiation exposure to surrounding tissues is crucial.

Market Players: The particle therapy market involves several key players, including manufacturers of particle therapy systems, treatment centers, and research institutions. Companies such as Varian Medical Systems, Hitachi, IBA, and Mevion Medical Systems are prominent manufacturers in this field.

Cost and Infrastructure: Establishing a particle therapy center requires significant investment in infrastructure and equipment. Particle therapy systems are complex and expensive, with costs typically in the range of tens to hundreds of millions of dollars.

Research and Development: Ongoing research and development efforts are focused on improving particle therapy techniques, optimizing treatment planning and delivery, reducing costs, and expanding access to more patients.

Market Outlook: The particle therapy market is expected to continue growing in the coming years. The increasing prevalence of cancer, coupled with the rising demand for advanced and precise cancer treatments, will drive market expansion.

Key Market Players:

Prominent players in the particle therapy market include IBA Worldwide (EU), Mevion Medical Systems (US), Varian Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Toshiba Medical Systems Corporation (Japan), and Provision Healthcare, LLC (US).

Inquiry before buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=12809137

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing

Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441